Publications of Martin A. Kohli
All genres
Journal Article (22)
1.
Journal Article
95, 109686 (2019)
Polymorphisms in the BDNF and BDNFOS genes are associated with hypothalamus-pituitary axis regulation in major depression. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 2.
Journal Article
18 (2), pp. 199 - 209 (2015)
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. NATURE NEUROSCIENCE 3.
Journal Article
37 (4), pp. 565 - 575 (2012)
Polymorphisms within the metabotropic glutamate receptor 1 gene are associated with depression phenotypes. Psychoneuroendocrinology 4.
Journal Article
106 (8), pp. 1263 - 1272 (2011)
Gene-PUFA interactions and obesity risk. British Journal of Nutrition 5.
Journal Article
44 (6), p. 295 - 295 (2011)
BDNF and NTRK2 polymorphisms and antidepressant treatment outcome. Pharmacopsychiatry 6.
Journal Article
16 (6), pp. 647 - 663 (2011)
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Molecular Psychiatry 7.
Journal Article
69 (9 Suppl.1), p. 152 S - 152 S (2011)
BDNF and NTRK2 Polymorphisms and Antidepressant Treatment Response. Biological Psychiatry 8.
Journal Article
15 (7), pp. 736 - 747 (2010)
Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Molecular Psychiatry 9.
Journal Article
67 (9 Suppl.1), pp. 127S - 128S (2010)
Polymorphisms in the BDNF Gene are Associated with Antidepressant Treatment Response. Biological Psychiatry 10.
Journal Article
67 (4), pp. 348 - 359 (2010)
Association of Genetic Variants in the Neurotrophic Receptor-Encoding Gene NTRK2 and a Lifetime History of Suicide Attempts in Depressed Patients. Archives of General Psychiatry 11.
Journal Article
73, pp. 665 - 666 (2009)
Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors. Annals of Human Genetics 12.
Journal Article
66 (9), pp. 966 - 975 (2009)
A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression. Archives of General Psychiatry 13.
Journal Article
42 (5), p. 224 - 224 (2009)
A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression. Pharmacopsychiatry 14.
Journal Article
42 (5), p. 226 - 226 (2009)
Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression. Pharmacopsychiatry 15.
Journal Article
42 (5), p. 230 - 230 (2009)
The neuronal transporter gene SLC6A15 confers risk to major depression. Pharmacopsychiatry 16.
Journal Article
18 (Suppl. 4), p. S296 - S296 (2008)
Variations in tryptophan hydroxylase 2 are associated with elevated risk for metabolic syndrome in depression. European Neuropsychopharmacology 17.
Journal Article
57, pp. 203 - 209 (2008)
Polymorphisms in the drug transporter Gene ABCB1 predict antidepressant treatment response in depression. Neuron 18.
Journal Article
105, pp. 177 - 184 (2008)
Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. Journal of Affective Disorders 19.
Journal Article
40 (5), p. 212 - 212 (2007)
SNPs in the NTRK2 gene are associated with depressive disorder. Pharmacopsychiatry 20.
Journal Article
40 (5), p. 212 - 212 (2007)
Susceptibility gene hunting for recurrent unipolar depression using 400k genome-wide genotype data. Pharmacopsychiatry